Evaluation of a suspicious oral mucosal lesion

Journal of the Canadian Dental Association

Volumn 74, Issue 3, 2008, Pages 275-280

  Williams, P Michele ^a,b,d   Poh, Catherine F ^a,b,c   Hovan, Allan J ^a,d   Ng, Samson ^a,e   Rosin, Miriam P ^a,b,f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c Oral Biopsy Service

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e VANCOUVER GENERAL HOSPITAL   (Canada)

^f SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; TOLONIUM CHLORIDE;

ANAMNESIS; BIOPSY; CANADA; DIFFERENTIAL DIAGNOSIS; DRINKING BEHAVIOR; FLUORESCENCE; HUMAN; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PHYSICAL EXAMINATION; PRECANCER; PREVENTIVE HEALTH SERVICE; REVIEW; SMOKING;

ALCOHOL DRINKING; BIOPSY; BRITISH COLUMBIA; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; FLUORESCENCE; HUMANS; MEDICAL HISTORY TAKING; MOUTH MUCOSA; MOUTH NEOPLASMS; PHYSICAL EXAMINATION; PRECANCEROUS CONDITIONS; PREVENTIVE HEALTH SERVICES; SMOKING; TOLONIUM CHLORIDE;

EID: 42149123718     PISSN: 07098936     EISSN: 14882159     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Laronde DM, Hislop TG, Elwood JM, Rosin MP. Oral cancer: just the facts. J Can Dent Assoc 2008; 74(3):269-72.
2. Neville BW, Damm DD, Allen CM, Bouqout JE. Allergic mucosal reactions to systemic drug administration. In: Oral and maxillofacial pathology. Philadelphia: WB Saunders; 2002. p. 300-2.
3. Poh CF, Williams PM, Zhang L, Rosin MP. Heads up! A call for dentists to screen for oral cancer. J Can Dent Assoc 2006; 72(5):413-6.
4. Axell T, Pindborg JJ, Smith CJ, Waal van der I. Oral white lesion with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 1986; 25(2):49-54.
5. Lesion-tracking sheet. Vancouver: BC Cancer Agency; 2008. Available: www.orcanet.ca/clinical (click Clinical Services, then Downloadable Forms).
6. Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, and others. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005; 65(17):8017-21.
7. Lane PM, Gilhuly T, Whitehead PD, Zeng H, Poh CF, Ng S, and others. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Optics 2006; 11(2):024006.
8. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, and others. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 2006; 15(22):6716-22.
9. Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, and others. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck 2007; 29(1):71-6.
10. Rosin MP, Poh CF, Elwood JM, Williams PM, Gallagher R, MacAulay C, and others. New hope for an oral cancer solution: together we can make a difference. J Can Dent Assoc 2008; 74(3):261-6.
11. The Early Detection of Oral Cancer Working Group. Guideline for the early detection of oral cancer in British Columbia 2008. BC Oral Cancer Prevention Program of the BC Cancer Agency. March 2008. Available: www.cdsbc.org/pdf/ OC_Guideline_Final_2008.pdf.
12. Poh CF, Ng S, Berean KW, Williams PM, Rosin MP, Zhang L. Biopsy and histopathologic diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2008; 74(3):283-8.